What Is Benzodiazepines? Drug Class, Schedule & Drug Test Answers
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: Benzodiazepines is a Depressant (GABA-A modulator). Schedule IV by prescription. Here's how the drug is classified, whether it's a narcotic/controlled substance, and what that means for testing.
What is Benzodiazepines?
Drug class: Depressant (GABA-A modulator)
Federal schedule: Schedule IV by prescription.
Benzos are not on the basic federal 5-panel, but they are included on most 10- and 12-panel employment screens. Whether your job tests for them depends entirely on panel size and employer policy.
Is Benzodiazepines a narcotic?
It is classified as a narcotic under the DEA's federal schedule. What matters more for you: Schedule IV by prescription..
Does it show up on drug tests?
No — it is not on the standard 5-panel; it appears only on expanded or panel-specific orders. See the full Benzos drug test guide for detection windows and cutoffs.
False-positive caution
- Sertraline (sertraline) and oxaprozin have documented case-report false positives for benzodiazepine immunoassays.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Does alprazolam Show up on a Drug Test?
No — Benzos is absent from standard drug panels. Full guide →
How Long Can Benzodiazepine Withdrawal Last?
How long Benzos stays detectable in your system (all test types) — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
How Long Do Benzodiazepines Stay in the Urine?
How long Benzos stays detectable in urine — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
What Can Cause a False Positive for Benzodiazepines?
Can Benzos trigger a false positive? Cross-reactivity evidence, confirmation testing, and how to clear your name with the MRO. Full guide →
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)